Market News AIOpen the app

LIMN stock news · Liminatus Pharma, Inc.

Stories about Liminatus Pharma, Inc. (LIMN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for LIMN

Follow Liminatus Pharma, Inc. (LIMN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LIMN
Free on the App Store and Google Play, or on the web.
  1. Nov 3, 2026, 4:21 PM ET · Deal

    Liminatus Pharma, Inc.: Entry into a Material Definitive Agreement (LIMN)

    Neutral

    Liminatus agreed to sell 260,001 shares for $2.50 each, raising $650,002.50 if the sale closes. The cash helps, but added shares balance that benefit, so the outlook is unchanged.